Across TCGA pan-cancer cohorts, CT83 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of CT83’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where CT83 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CT83 is over-expressed in tumor.
STAD, LUAD, and LUSC are the cancer types where CT83 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CT83 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.